NCT03618095: A trial that was reported late by Boston Scientific Corporation
This trial has reported, although it was 76 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03618095 |
|---|---|
| Title | REPRISE IV: REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of LOTUS Edge Valve System in IntermediatE Surgical Risk Subjects |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 14, 2019 |
| Completion date | March 30, 2021 |
| Required reporting date | March 30, 2022, midnight |
| Actual reporting date | June 14, 2022 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 76 |